Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 23.11% Profit

June 10, 2024
On February 6, 2024, QuantWave's forecast signal for ELI LILLY AND COMPANY indicated a long position with the stock trading at 697.82 $. Today, on June 10, 2024, the stock reached the forecasted target price of 859.12 $, resulting in a profit of 23.11%.

This achievement highlights the accuracy and reliability of QuantWave's analytics in predicting stock movements. The successful forecast for ELI LILLY AND COMPANY demonstrates the platform's ability to provide valuable insights for investors looking to make informed decisions in the market.

Several factors may have contributed to the stock's movement in line with the forecast. ELI LILLY AND COMPANY's strong financial performance, positive market sentiment towards the healthcare sector, and strategic business decisions could have all played a role in driving the stock price higher.

QuantWave, as an automated forecasting platform, continues to offer users access to predictions for a wide range of stocks, presenting opportunities for potential profits. For those interested in delving deeper into the investment strategy behind QuantWave's forecasts, exploring the educational resources of QuantSchool is recommended. QuantSchool provides a comprehensive professional investment framework that reveals key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

LLYFebruary 25, 2025Major Stock Movement: Lilly to participate in TD Cowens 45th Annual Health Care Conference  ~2 min.

Eli Lilly and Company (LLY) has recently caught the attention of investors as it prepares to participate in the TD Cowens 45th Annual Health Care Conference....

UNHJuly 30, 2024UNITEDHEALTH GROUP INCORPORATED Hits 7.86% Profit Target as Forecasted by QuantWave  ~2 min.

UNITEDHEALTH GROUP INCORPORATED (NYSE: UNH) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 7.86% for investors....

UNHJuly 17, 2024UNITEDHEALTH GROUP INCORPORATED Stock Hits Forecast Price Target with 8.72% Profit Gain  ~1 min.

On November 6, 2023, QuantWave issued a long signal for UNITEDHEALTH GROUP INCORPORATED when the stock was trading at 521.22 $....

BMYNovember 11, 2024BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 13.38% Profit  ~1 min.

On October 22, 2024, QuantWave issued a forecast signal for BRISTOL-MYERS SQUIBB COMPANY with a price target of $58.53, predicting a long position. The stock was trading at $51....

UNHJuly 17, 2024QuantWave Achieves 10.63% Profit Target Forecast for UnitedHealth Group Incorporated  ~1 min.

UNITEDHEALTH GROUP INCORPORATED's stock has successfully reached the price target forecast by QuantWave with a profit of 10.63%. The forecast signal was issued on 2023-10-10 at a price of 508....

ABTFebruary 21, 2024ABBOTT LABORATORIES Hits Price Target Forecast with 11.61% Profit  ~1 min.

QuantWave, an automated forecasting platform, successfully predicted the price movement of ABBOTT LABORATORIES stock, achieving an 11.61% profit on the forecasted long position....